alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Michigan Supreme Court Lansing, Michigan

Marilyn Kelly, Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk November 23, 2009

d1116 

# Order

November 23, 2009

138968 & (23)

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 138968 COA: 288020 Wayne CC: 93-011714-FC ERIC L. FRENCH, a/k/a WAHEED M. MUHAMMAD, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application fo r leave to appeal th e February 25, 2009 order of the Court of Appeals is considered , and it is DENIED, because the defendant has
failed to meet the burden of establishing entitlement to re lief under MCR 6.508(D). The
motion to remand is DENIED.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2429 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2429

      To extend the temporary suspension of duty on tebufenozide.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

  Mr. Schumer introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
      To extend the temporary suspension of duty on tebufenozide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TEBUFENOZIDE.

    (a) In General.--Heading 9902.05.17 of the Harmonized Tariff 
Schedule of the United States (relating to tebufenozide) is amended by 
striking the date in the effective period column and inserting ``12/31/
2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Frankie Thomas ROGERS v. Ken MOORE et al.

2150976

Court of Civil Appeals of Alabama.

February 10, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
James GOLDBERG, Appellant, v. Seth A. KANEGIS, et al., Appellees.

No. 3D16-2803

District Court of Appeal of Florida, Third District.

Opinion filed February 21, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
II 

112TH CONGRESS 

2D SESSION S. 2605 

To extend and modify the temporary reduction of duty on cyan 1 RO inkjet 

printing ink. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CARPER (for himself and Mr. COONS) introduced the following bill; which 

was read twice and referred to the Committee on Finance 

A BILL 

To extend and modify the temporary reduction of duty on 

cyan 1 RO inkjet printing ink. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CYAN 1 RO INKJET PRINTING INK. 

4 (a) IN GENERAL.—Heading 9902.40.42 of the Har5 monized Tariff Schedule of the United States (relating to 

6 cyan 1 RO inkjet printing ink) is amended— 

7 (1) by striking ‘‘0.3%’’ in the column 1 general 

8 rate of duty column and inserting ‘‘Free’’; and 

9 (2) by striking the date in the effective period 

10 column and inserting ‘‘12/31/2015’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2605 IS

1 (b) EFFECTIVE DATE.—The amendments made by 

2 subsection (a) apply with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
Exhibit 31.1—Section 302 Certification
I, Ellen Z. Lamale, certify that:
I have reviewed this annual report on Form 10-K, and all reports on Form 8-K containingdistribution or servicing reports filed in respect of period included in the year covered bythis annual report, of Principal Life Income Fundings Trust 2004-49;
1.  Based on my knowledge, the information in these reports, taken as a whole, does not containany untrue statement of a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements were made, notmisleading as of the last day of the period covered by this annual report; 2.  Based on my knowledge, the distribution or servicing information required to be provided tothe depositor by the trustee under the pooling and servicing, or similar agreement, forinclusion in these reports is included in these reports; 3.  I am responsible for reviewing the activities performed by the depositor and the trusteeunder the pooling and servicing, or similar agreement, and based upon my knowledge and theannual compliance review required under that agreement, and except as disclosed in thereports, the depositor and trustee have each fulfilled its obligations under that agreement;and 4.  The reports disclose all significant deficiencies relating to the compliance by the trusteeand the depositor with the minimum servicing or similar standards based upon the reportprovided by an independent public accountant, after conducting a review in compliance with theUniform Single Attestation Program for Mortgage Bankers or similar procedures, as set forth inthe pooling and servicing, or similar agreements, that is included in these reports.
In giving the certifications above, I have reasonably relied on information provided to me by thefollowing unaffiliated parties: Ernst and Young and Citibank, N.A.
Date: March 29, 2005   By: /s/ Ellen Z. LamaleName: Ellen Z. LamaleTitle: Senior Vice President and Chief Actuary
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2682 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2682

To suspend temporarily the duty on Strong Base Anionic Resin-Quaternary 
      amine styrene divinylbenzene copolymer in the chloride form.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To suspend temporarily the duty on Strong Base Anionic Resin-Quaternary 
      amine styrene divinylbenzene copolymer in the chloride form.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. STRONG BASE ANIONIC RESIN-QUATERNARY AMINE STYRENE 
              DIVINYLBENZENE COPOLYMER IN THE CHLORIDE FORM.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Strong Base         Free         No change        No change        On or before 12/  ''.
                        Anionic Resin-                                                     31/2015.......
                        Quaternary amine
                        styrene
                        divinylbenzene
                        copolymer in the
                        chloride form
                        (CAS No. 69011-15-
                        0) (provided for
                        in subheading
                        3914.00.60)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Vladimir Calafet PIA, Appellant, v. The STATE of Florida, Appellee.

No. 3D17-2456

District Court of Appeal of Florida, Third District.

Opinion filed March 28, 2018

Prada Urizar, PLLC and Mark A. Prada, for appellant.

Pamela Jo Bondi, Attorney General, and Michael W. Mervine, Assistant Attorney General, for appellee.

Before SUAREZ, LAGOA, and LINDSEY, JJ.

PER CURIAM.

Affirmed. *Jules v. State*, 233 So.3d 1196 (Fla. 3d DCA 2017) ; *State v. Green*, 944 So.2d 208 (Fla. 2006).
Exhibit
      32.1





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Annual Report of Curatech Industries, Inc. (the "Company")
      on Form 10-KSB for the year ending December 31, 2007, as filed with the
      Securities and Exchange Commission on the date hereof (the "Report"), I, Lincoln
      M. Dastrup, Chief Executive Officer of the Company, certify pursuant to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that, to the best of my knowledge and belief:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




/s/
      Lincoln M. Dastrup


Lincoln
      M. Dastrup


Chief
      Executive Officer


April
      15,
      2008




A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement has been
      provided to the Company and will be retained by the Company and furnished to
      the
      Securities and Exchange Commission or its staff upon request. The foregoing
      certifications are accompanying the Company's Form 10-KSB solely pursuant to
      section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
      section 1350, chapter 63 of title 18, United States Code )
      and is
      not being filed as part of the Form 10-KSB or as a separate disclosure
      document.
STATE EX REL. Marcellus ADAMS v. STATE of Louisiana

No. 2017-KH-0229

Supreme Court of Louisiana.

April 20, 2018

**ON SUPERVISORY WRITS TO THE FIRST JUDICIAL DISTRICT COURT, PARISH OF CADDO**

PER CURIAM:

Denied. Relator fails to show he received ineffective assistance of counsel under the standard of *Strickland v. Washington* , 466 U.S. 668, 104 S.Ct. 2052, 80 L.Ed.2d 674 (1984). As to his remaining claims, relator fails to satisfy his post-conviction burden of proof. La.C.Cr.P. art. 930.2.

Relator has now fully litigated his application for post-conviction relief in state court. Similar to federal habeas relief, *see*28 U.S.C. § 2244, Louisiana post-conviction procedure envisions the filing of a successive application only under the narrow circumstances provided in La.C.Cr.P. art. 930.4 and within the limitations period as set out in La.C.Cr.P. art. 930.8. Notably, the Legislature in 2013 La. Acts 251 amended that article to make the procedural bars against successive filings mandatory. Relator's claims have now been fully litigated in accord with La.C.Cr.P. art. 930.6, and this denial is final. Hereafter, unless he can show that one of the narrow exceptions authorizing the filing of a successive application applies, relator has exhausted his right to state collateral review. The district court is ordered to record a minute entry consistent with this per curiam.
II 

118TH CONGRESS 

1ST SESSION S. 1214 

To set forth limitations on exclusive approval or licensure of drugs designated 

for rare diseases or conditions. 

IN THE SENATE OF THE UNITED STATES 

APRIL 19, 2023 

Ms. BALDWIN introduced the following bill; which was read twice and referred 

to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To set forth limitations on exclusive approval or licensure 

of drugs designated for rare diseases or conditions. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Retaining Access and 

5 Restoring Exclusivity Act’’ or the ‘‘RARE Act’’. 

6 SEC. 2. LIMITATIONS ON EXCLUSIVE APPROVAL OR LICEN7 SURE OF ORPHAN DRUGS. 

8 (a) IN GENERAL.—Section 527 of the Federal Food, 

9 Drug, and Cosmetic Act (21 U.S.C. 360cc) is amended— 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 1214 IS

1 (1) in subsection (a), in the matter following 

2 paragraph (2), by striking ‘‘same disease or condi3 tion’’ and inserting ‘‘same approved use or indica4 tion within such rare disease or condition’’; 

5 (2) in subsection (b)— 

6 (A) in the matter preceding paragraph (1), 

7 by striking ‘‘same rare disease or condition’’ 

8 and inserting ‘‘same approved use or indication 

9 for which such 7-year period applies to such al10 ready approved or licensed drug’’; and 

11 (B) in paragraph (1), by inserting ‘‘, relat12 ing to the approved use or indication,’’ after 

13 ‘‘the needs’’; 

14 (3) in subsection (c)(1), by striking ‘‘same rare 

15 disease or condition as the already approved drug’’ 

16 and inserting ‘‘same use or indication for which the 

17 already approved or licensed drug was approved or 

18 licensed’’; and 

19 (4) by adding at the end the following: 

20 ‘‘(f) APPROVED USE OR INDICATION DEFINED.—In 

21 this section, the term ‘approved use or indication’ means 

22 the use or indication approved under section 505 of this 

23 Act or licensed under section 351 of the Public Health 

24 Service Act for a drug designated under section 526 for 

25 a rare disease or condition.’’. 


kjohnson on DSK79L0C42PROD with BILLS
3 

•S 1214 IS

1 (b) APPLICATION OF AMENDMENTS.—The amend2 ments made by subsection (a) shall apply with respect to 

3 any drug designated under section 526 of the Federal 

4 Food, Drug, and Cosmetic Act (21 U.S.C. 360bb), regard5 less of the date on which the drug was so designated, and 

6 regardless of the date on which the drug was approved 

7 under section 505 of such Act (21 U.S.C. 355) or licensed 

8 under section 351 of the Public Health Service Act (42 

9 U.S.C. 262). 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 06-6094

ANTHONY J. TURNER, Petitioner - Appellant, versus GENE M. JOHNSON, Director, Virginia Department of Corrections, Respondent - Appellee. Appeal from the United States District Court for the Eastern District of Virginia, at Norfolk. Robert G. Doumar, Senior District Judge. (2:05-cv-00683-RGD) Submitted: May 18, 2006 De cided: May 31, 2006 Before WIDENER and WILKINSON, Circuit Judges, and HAMILTON, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Anthony J. Turner, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: Anthony J. Turner, a Virginia inmate, seeks to appeal the district court’s order dismissing without prejudice his petition filed under 28 U.S.C. § 2254 (2000) as an unauthorized second or successive petition. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000); Jones v. Braxton , 392 F.3d 683 (4th Cir. 2004). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by demonstrating that reasonable jurists would find the district court’s assessment of his constitutional claims debatable and that any dispositive procedural rulings by the district court are also debatable or wrong. SeeMiller-El v. Cockrell , 537 U.S. 322, 336 (2003); Slack v. McDaniel , 529 U.S. 473, 484 (2000); Rose v. Lee , 252 F.3d 676, 683 (4th Cir. 2001). We have independently reviewed the record and conclude that Turner has not made the requisite showing. Accordingly, we deny a certificate of appealability, and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Exhibit 32.2CERTIFICATION(Not filed pursuant to the Securities Exchange Act of 1934)     Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-OxleyAct of 2002, the undersigned, Steven D. Foster, the Chief Financial Officer of Parallel PetroleumCorporation (“Parallel”), hereby certifies that the Quarterly Report on Form 10-Q of Parallel forthe quarter ended March 31, 2008 fully complies with the periodic reporting requirements of theSecurities Exchange Act of 1934, as amended, and the information contained in that Form 10-Q Reportfairly presents, in all material respects, the financial condition and results of operations ofParallel.Date: May 5, 2008               /s/ Steven D. Foster   Steven D. Foster,   Chief Financial Officer        A signed original of this written statement required by Section 906 has been provided toParallel Petroleum Corporation and will be retained by Parallel Petroleum Corporation and furnishedto the Securities and Exchange Commission or its staff upon request.
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

AMBER LANE, )

)

Appellant, )

)

v. )

) Case No. 2D17-120

STATE OF FLORIDA, ) 

)

Appellee. )

)

Opinion filed April 25, 2018.

Appeal from the Circuit Court for 

Hillsborough County; Vivian T. Corvo, 

Judge.

Howard L. Dimmig, II, Public Defender,

and Judith Ellis, Assistant Public Defender, 

Bartow, for Appellant.

Pamela Jo Bondi, Attorney General, 

Tallahassee, and Susan M. Shanahan, 

Assistant Attorney General, Tampa, for 

Appellee.

PER CURIAM.

Affirmed. 

KELLY, SLEET, and BADALAMENTI, JJ., Concur.
**Exhibit 31.1**

 

**CERTIFICATIONS**

 

I, Wayne B. Fuquay, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Analytical Surveys, Inc.; 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; 

 

3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; 

 

4. The registrant’s other certifying officer(s) and I are responsiblefor establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and the registrant’s have: 

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed underour supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is beingprepared; 

 

b) Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this quarterly report based on suchevaluation; and 

 

c) Disclosed in this quarterly report anychange in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: May 17, 2004 

 

/s/ Wayne B. Fuquay 

Wayne B. Fuquay 

Chief Executive Officer
| Úradný vestníkEurópskej únie | ISSN 1725-5147L 289Zväzok 51**30. októbra 2008** |
| --- | --- |

Úradný vestníkEurópskej únie

ISSN 1725-5147L 289Zväzok 51**30. októbra 2008**

| Slovenské vydanie | | Právne predpisy | | |
| --- | --- | --- | --- | --- |
| |
| Obsah | | II *Akty prijaté podľa Zmluvy o ES/Zmluvy o Euratome, ktorých uverejnenie nie je povinné* | |
| | | **ROZHODNUTIA** |
| | | **Rada** |
| | | **2008/805/EC** | |
| | ***** | **Rozhodnutie Rady z 15. júla 2008 o podpise a predbežnom vykonávaní Dohody o hospodárskom partnerstve medzi štátmi CARIFORUM-u na jednej strane a Európskym spoločenstvom a jeho členskými štátmi na druhej strane** | 1 |
| | | **Dohoda o hospodárskom partnerstve medzi štátmi CARIFORUM-u na jednej strane a Európskym spoločenstvom a jeho členskými štátmi na druhej strane** | 3 |
| | |
| | | |
| | | Poznámka pre čitateľa (pozri vnútornú stranu zadnej obálky) | s3 |

Slovenské vydanie

Právne predpisy

---

Obsah

II *Akty prijaté podľa Zmluvy o ES/Zmluvy o Euratome, ktorých uverejnenie nie je povinné*

**ROZHODNUTIA**

**Rada**

**2008/805/EC**

*****

**Rozhodnutie Rady z 15. júla 2008 o podpise a predbežnom vykonávaní Dohody o hospodárskom partnerstve medzi štátmi CARIFORUM-u na jednej strane a Európskym spoločenstvom a jeho členskými štátmi na druhej strane**

1

**Dohoda o hospodárskom partnerstve medzi štátmi CARIFORUM-u na jednej strane a Európskym spoločenstvom a jeho členskými štátmi na druhej strane**

3

---

Poznámka pre čitateľa (pozri vnútornú stranu zadnej obálky)

s3

| **SK** | Akty, ktoré sú vytlačené obyčajným písmom, sa týkajú každodennej organizácie poľnohospodárskych záležitostí a sú spravidla platné len obmedzený čas.Názvy všetkých ostatných aktov sú vytlačené tučným písmom a je pred nimi hviezdička. |
| --- | --- |

**SK**

---

Akty, ktoré sú vytlačené obyčajným písmom, sa týkajú každodennej organizácie poľnohospodárskych záležitostí a sú spravidla platné len obmedzený čas.Názvy všetkých ostatných aktov sú vytlačené tučným písmom a je pred nimi hviezdička.

---
[Federal Register Volume 74, Number 74 (Monday, April 20, 2009)]
[Notices]
[Page 17994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8940]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-65,591]


ABF Freight Systems Incorporated, Dayton, OH; Notice of 
Termination of Investigation

    Pursuant to Section 221 of the Trade Act of 1974, as amended, an 
investigation was initiated on March 13, 2009 in response to a petition 
filed on behalf of workers of ABF Freight Systems Incorporated, Dayton, 
Ohio.
    The petitioners have requested that the petition be withdrawn. 
Consequently, the investigation has been terminated.

    Signed at Washington, DC, this 27th day of March 2009.
Elliott S. Kushner,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-8940 Filed 4-17-09; 8:45 am]
BILLING CODE 4510-FN-P